Mark Spahr

A Michigan native, Mark earned his Bachelor’s in Biology and Masters in Microbiology and Immunology at the University of Michigan. He brings a broad depth of experience from three decades of work in the biopharmaceutical industry, including Merck & Co, Parke-Davis/Warner Lambert, Pfizer, Cayman Chemical, Lycera, and IFM Therapeutics. He specializes in a wide range of assay development and problem-solving and loves taking on new challenges to help bring products to the market and support the current product lines. A true scientist, he loves working with new technologies and how to apply them to his work at hand.